NASDAQ (usa) |
![]() |
6715.56 | -12.11 | -0.18% |
FTSE 100 (london) |
![]() |
7487.96 | -5.12 | -0.07% |
DAX (german) |
![]() |
13465.51 | 235.94 | 1.78% |
NIKKEI 225 (japan) |
![]() |
22420.08 | 408.47 | 1.86% |
Hang - Seng (hong kong) |
![]() |
28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) |
![]() |
3391.61 | 17.53 | 0.52% |
KOSPI (korea) |
![]() |
2556.47 | 33.04 | 1.31% |
All Ordinaries (australia) |
![]() |
6005.30 | 28.90 | 0.48% |
BOVESPA (brazil) |
![]() |
74092.76 | -215.73 | -0.29% |
Clearside Biomedical Inc (NASDAQ: CLSD)
CLSD Technical Analysis
5
As on 16th May 2025 CLSD STOCK Price closed @ 0.88 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 1.26 & Strong Sell for SHORT-TERM with Stoploss of 1.23 we also expect STOCK to react on Following IMPORTANT LEVELS. |
CLSDSTOCK Price
Open | 0.86 | Change | Price | % |
High | 0.91 | 1 Day | 0.02 | 2.33 |
Low | 0.85 | 1 Week | 0.03 | 3.53 |
Close | 0.88 | 1 Month | -0.02 | -2.22 |
Volume | 325179 | 1 Year | -0.13 | -12.87 |
52 Week High 2.02 | 52 Week Low 0.75 |
NASDAQ USA Most Active Stocks
AFMD | 0.28 | 211.11% |
AMRS | 0.14 | 100.00% |
HCTI | 0.01 | -75.00% |
BON | 0.06 | 20.00% |
PLUG | 0.77 | 10.00% |
NVDA | 135.40 | 0.42% |
AGMH | 0.07 | 16.67% |
GNLN | 0.01 | 0.00% |
LCID | 2.84 | 5.58% |
LMDX | 0.02 | 0.00% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
CLSD Daily Charts |
CLSD Intraday Charts |
Whats New @ Bazaartrend |
CLSD Free Analysis |
|
CLSD Important Levels Intraday
RESISTANCE | 1.00 |
RESISTANCE | 0.96 |
RESISTANCE | 0.94 |
RESISTANCE | 0.91 |
SUPPORT | 0.85 |
SUPPORT | 0.82 |
SUPPORT | 0.80 |
SUPPORT | 0.76 |
CLSD Forecast May 2025
4th UP Forecast | 1.92 |
3rd UP Forecast | 1.59 |
2nd UP Forecast | 1.38 |
1st UP Forecast | 1.17 |
1st DOWN Forecast | 0.59 |
2nd DOWN Forecast | 0.38 |
3rd DOWN Forecast | 0.17 |
4th DOWN Forecast | -0.16 |
CLSD Weekly Forecast
4th UP Forecast | 1.42 |
3rd UP Forecast | 1.25 |
2nd UP Forecast | 1.14 |
1st UP Forecast | 1.03 |
1st DOWN Forecast | 0.73 |
2nd DOWN Forecast | 0.62 |
3rd DOWN Forecast | 0.51 |
4th DOWN Forecast | 0.34 |
CLSD Forecast2025
4th UP Forecast | 3.62 |
3rd UP Forecast | 2.74 |
2nd UP Forecast | 2.2 |
1st UP Forecast | 1.65 |
1st DOWN Forecast | 0.11 |
2nd DOWN Forecast | -0.44 |
3rd DOWN Forecast | -0.98 |
4th DOWN Forecast | -1.86 |
Clearside Biomedical Inc ( NASDAQ USA Symbol : CLSD )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
CLSD Other Details
Segment | EQ | |
Market Capital | 320595040.00 | |
Sector | Healthcare | |
Industry | Biotechnology | |
Offical website | > echo $website ; ?> |
CLSD Address
![]() |
CLSD Latest News
CLSD Business Profile
Clearside Biomedical, Inc., a biopharmaceutical company, engages in the developing and delivering treatments that restore and preserve vision for people with serious eye diseases. Its product includes CLS-AX, an axitinib for suprachoroidal injection which is in Phase 1/2a clinical trial. It also develops XIPERE, a triamcinolone acetonide suprachoroidal injectable suspension for the treatment of macular edema associated with uveitis, diabetic macular edema, and macular edema associated with retinal vein occlusion. The company was incorporated in 2011 and is headquartered in Alpharetta, Georgia. Address: 900 North Point Parkway, Alpharetta, GA, United States, 30005
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service